How to stop a 90% revenue crash: Mapping patent thickets to survive the new exclusivity slope
A $90M revenue cliff doesn’t happen overnight. It happens because someone mapped the wrong future.
If you’re in pharma—commercial, strategy, legal, or business development—you’ve probably felt the chill: a product that “should” be protected suddenly is…
